OverviewSuggest Edit

Hofseth BioCare, a biotech company, develops, manufactures, markets and sells marine ingredients and finished products for humans and pets. Its products include OmeGo salmon oil; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; and CalGo, a marine calcium powder produced from salmon bones that enhances bone density and bone deposition in older individuals.

HQÅlesund, NO

Latest Updates

Employees (est.) (Feb 2019)46
Share Price (Jun 2020)KR9.4

Key People/Management at Hofseth BioCare

Hofseth As

Hofseth As

Board Member
Roger Hofseth

Roger Hofseth

Syvde Eiendom

Syvde Eiendom

Chairman of the Board
Jon Olav Ødegård

Jon Olav Ødegård

Hofseth Biocare

Hofseth Biocare

ASA, Board Member
Karl Inge Slotsvik

Karl Inge Slotsvik

Show more

Hofseth BioCare Office Locations

Hofseth BioCare has an office in Ålesund
Ålesund, NO (HQ)
Havnegata 11
Show all (1)

Hofseth BioCare Financials and Metrics

Hofseth BioCare Revenue

Market capitalization (3-Jun-2020)


Closing stock price (3-Jun-2020)

Hofseth BioCare's current market capitalization is kr3.1 b.
Show all financial metrics

Hofseth BioCare Online and Social Media Presence

Embed Graph

Hofseth BioCare News and Updates

Hofseth Biocare ASA: Proxy Rights at Annual General Meeting

Ola Holen, Chairman of the Board of Hofseth BioCare ASA, has in connection to the upcoming Annual General Meeting on 25 May 2020, received proxy rights from shareholders representing 158 596 305 shares in the company, equal to approx. 48.2 per cent of the voting rights.

Hofseth Biocare ASA: HBC Annual Report and ESG Report 2019

Today, 20 March 2020, the Board of Directors approved the Annual Report for 2019.

Hofseth Biocare ASA: Fourth Quarter 2019 Financial Report

Hofseth BioCare ASA ("HBC") had operating revenues of NOK 11.1m (NOK 14.5m) in the fourth quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 8.4m (NOK 9.9m) in the period. Operational profit (EBITDA) for the fourth quarter 2019 was negative NOK 15.0m (NOK 13.1m). Net financial items in the f…


On January 1, 2020, a merger between Yokohama Reito Co., Ltd. ("Yokorei") and its wholly owned subsidiary, Alliance Seafoods Inc., the latter being the owner of 40,951,333 shares in Hofseth Biocare ASA, constituting 12.57% of the total number of shares, has become effective with Yokorei as the survi…

Hofseth Biocare ASA: Third Quarter 2019 Financial Report

Hofseth BioCare had operating revenues of NOK 29.2m (16.9m) in the third quarter of 2019.


Hofseth BioCare ASA ("HBC") has entered into a consultancy agreement with Dr. Crawford Currie to strengthen the IR and communications functions of HBC.
Show more

Hofseth BioCare Frequently Asked Questions

  • When was Hofseth BioCare founded?

    Hofseth BioCare was founded in 2000.

  • Who are Hofseth BioCare key executives?

    Hofseth BioCare's key executives are Hofseth As, Roger Hofseth and Syvde Eiendom.

  • How many employees does Hofseth BioCare have?

    Hofseth BioCare has 46 employees.

  • Who are Hofseth BioCare competitors?

    Competitors of Hofseth BioCare include Lidtke Technologies, Sundown Nutrition and Coromega.

  • Where is Hofseth BioCare headquarters?

    Hofseth BioCare headquarters is located at Havnegata 11, Ålesund.

  • Where are Hofseth BioCare offices?

    Hofseth BioCare has an office in Ålesund.

  • How many offices does Hofseth BioCare have?

    Hofseth BioCare has 1 office.